医学
胶质母细胞瘤
疾病
重症监护医学
替莫唑胺
临床试验
专家意见
肿瘤科
内科学
癌症研究
作者
Vincenzo Di Nunno,Enrico Franceschi,Alicia Tosoni,Monica Di Battista,Lidia Gatto,Cinzia Lamperini,Santino Minichillo,Antonella Mura,Stefania Bartolini,Alba A. Brandes
标识
DOI:10.1080/14737140.2020.1807949
摘要
Background Almost all patients affected by glioblastoma experience recurrence of the disease.Areas covered Management of recurrent glioblastoma is a clinical challenge, and several elements should be taken into consideration when making treatment choice. Loco-regional treatments may be the best treatment approach in selected cases while systemic therapies or supportive care alone are necessary for other patients. Unfortunately, few drugs have shown clinical in this setting. This lack of effective treatments has made recurrent glioblastoma a disease orphan of an effective approach.Expert opinion Results of recent clinical trials offer interesting perspectives and may controvert this axiom.
科研通智能强力驱动
Strongly Powered by AbleSci AI